Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Q4: Bubs (ASX:BUB) share price on watch

The Bubs Australia Ltd (ASX:BUB) share price is on watch today after releasing its FY21 fourth quarter revenue and growth numbers.

The Bubs Australia Ltd (ASX: BUB) share price is on watch today after releasing its FY21 fourth quarter revenue numbers.

Bubs FY21 fourth quarter

The infant formula business said that its fourth quarter showed quarterly gross revenue of $12.8 million, up 8% on the third quarter.

Bubs also said that it delivered on a modest increase in gross revenue for the half, up 10% (half on half) to $24.6 million.

However, the total FY21 revenue was $46.8 million, down 24% year on year which reflects the prolonged COVID-19 disruption.

It ended with a cash balance of $27.9 million, which is sufficient to fund the business for 11 quarters according to management.

Bubs broke down some of the individual highlights:

Domestic

Its domestic retail continues to perform strongly. Infant formula gross revenue to Australian major grocery and and pharmacy chains were up 67% quarter on quarter.

China

The company also pointed to a recovery of China demand. Group gross revenue to cross-border e-commerce (CBEC) was up 10% with Bubs infant formula CBEC revenue up 15%.

Gross revenue to the corporate daigou channel was up 166%, with Bubs infant formula gross revenue to corporate daigou channel up “17x”.

Bubs also said that its adult milk powder gross revenue (predominately CapriLac) was up 6% across all channels, with CBEC rising 4% year on year and 42% quarter on quarter.

International expansion

Bubs said that its quarterly international gross revenue was up 224% year on year and up 48% quarter on quarter (including ingredient sales), with Bubs products revenue growth of 56% quarter on quarter.

In the US, the first batches of the FDA label compliant Aussie Bubs goat and milk toddler formula products produced and shipped for sale on Walmart.com and Amazon.com in September.

Outlook for Bubs and the share price

Bubs said that it has made good progress in executing its COVID-19 recovery strategy. It said it’s well placed to return to “accelerating topline revenue growth in FY22”, but the pandemic continues to have an effect with lockdowns and so on.

The growth is not what the company would have liked in 2021, but it’s good to see that it is steadily growing. The domestic performance in Australian retail looks good, as well as the international growth. Those two areas could power the business forwards as they become larger parts of the overall picture.

Today’s low(er) price may represent a high-risk, long-term opportunity. But I’d expect plenty of volatility ahead.

There are other ASX growth shares that may have easier paths to good profit growth.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content